- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Unmet Needs In Agitation Associated With Alzheimer’s Dementia (AAD)
This is a Virtual Live Event for PsychU members in Florida and Georgia.
This evidence-based review highlights important aspects of agitation associated with Alzheimer’s Dementia (AAD) for better understanding of the prevalence and challenges in diagnosis of AAD. We will also explore the potential pathobiological correlations in AAD, describe the clinical and humanistic burden as well as current guidelines for treatments of this complex and prominent complication of an already devastating disease.

Marc E. Agronin, MD
Agitation Section Advisor; President of the American Association for Geriatric Psychiatry (AAGP); Senior Vice President for Behavioral Health and Chief Medical Office for the Memory and Research Center at MIND Institute; Affiliate Associate Professor of Psychiatry and Neurology at the University of Miami Miller School of Medicine

Aneta Fornal, PharmD (OPDC)
Medical Science Liaison
Speaker Marc Agronin, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Speaker Aneta Fornal, PharmD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)